Efficacy and safety of sepetaprost in patients with primary open-angle glaucoma or ocular hypertension: results from the randomised, phase 3 ANGEL-J1 study
Inatani M., Kanamori A., Inai M., Ikeda T., Angeles R.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Clinical development
-
Affiliations
Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Yoshida, Japan; Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; Kanamori Eye Clinic, Akashi, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Japan; Santen Inc., 2100 Powell Street, Suite 800, Emeryville, CA, 94608, USA.